Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer
PaperCitations, authors & open-access status
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 45 citations, 2016 year and gold oa status.
45
Citations
2016
Year
gold
OA Status